BioProcess Technology Consultants (BPTC) is the leader in #biologics CMC consulting, offering technical, regulatory, and strategic services from clone to clinic
Congratulations to #Ridgebackbio on this significant milestone. We are pleased to support your efforts in developing EIDD-2801 and wish you the greatest success! XCOVID19 #CURECOVID#FDA#BDO https://t.co/70FvaZ75ll
BDO’s BioProcess Technology Group is currently recruiting consultants with experience and expertise in late stage downstream processing, cell line development, and quality control. Potential candidates should have an advanced degree in a relevant discipli…https://t.co/0mE6xmlqXA
LinkedIn share: Join BDO’s @PattiSeymour for a panel discussion on key trends impacting the pharma industry and pharma/biopharma manufacturing and supply, March 24 in NYC. #DCATWeek2020 https://t.co/tpOfDT3aLC
Join BDO’s @LanceMinor for a panel discussion on Cell and Gene Therapy: The Next Generation of Personalized Medicine, at the Columbia Business School Healthcare annual event, Feb 28, NYC. #cellandgenetherapy#lifesciences https://t.co/o39ygS8LTZ
For BDO’s views on the key trends driving activity in today’s life sciences industry, read our latest insights at https://t.co/xZnEDEaSMG
#lifesciences#drugdevelopment#healthcare https://t.co/VtcKS6tDVx
The Massachusetts Life Sciences Center is accepting applications for its 2019 Tax Incentive Program. The state has allotted $20,000,000 to this year’s program to help grow MA’s Life Sciences ecosystem through MA job creation. To be eligible for this progr…https://t.co/vcE9KnWDFI
Congratulations! This is a great advance in the development of cost effective vaccines for the developing world. #drugdevelopment#vaccinessavelives https://t.co/Xwwh1jp5gd
BDO-BioProcess Technology Group's Lisa Cozza to present at the Society of Physician Entrepreneurs event tonight on "Vetting the Vendors-Ensuring your product contract service providers are your partners in Gaithersburg, MD. https://t.co/MK96awRjpt
In addition to experts in cell and gene therapy, we also have openings for QA auditors and regulatory affairs specialists
#Genetherapy#viralvectors#qa#regulatoryaffairs https://t.co/VqMnCzUdJg
BDO-BPTG’s Frank Riske finds that non-Mab affinity chromatography is available from innovators who can generate affinity ligands and resins in as little as eight weeks. This timing makes it practical for affinity purification of non-Mab, non-Fc proteins. https://t.co/oznHdZB0E0
BDO-BPTG bioTRAK® Director, Dawn Eckers comments in interview that bio manufacturing will increase by 45% to 6,400 kL over five years. But with demand growing at over 10% per year and Alzheimer's there may still be a shortage in capacity on the horizon. https://t.co/QWrFh9rgWQ
As the BioProcess Technology Group continues to grow and expand our services, we are pleased to have Neal Gordon join our team. #BPTG#bioprocess#technology https://t.co/Yjf6nX3U2L
Neal Gordon the well-known Boston biotech entrepreneur has joined BDO’s BioProcess Technology Group (BPTG) as a Managing Director. Neal’s added leadership will assist BDO-BPTG to continue to expand its consulting services and grow its global client base. https://t.co/z1jcNGh3vQ
BPTG’s blog entitled, “The Cell and Gene Therapy Toolbox”, identifies and suggests approaches to a number of the CMC and related regulatory challenges facing the fast-moving, innovative cell and gene therapy product development field.
https://t.co/Gi6YdPlsEs
Anna Gilbert ASQ, CQA, Director at BDO-BPTG is a course faculty member at the upcoming Cell Therapy Training Course, October 21-25, 2019, in Philadelphia, PA. Anna's presentation is focused on Quality Systems: Requirements for Virtual Companies. https://t.co/WQ5hAV2elb
Patti Seymour at BDO’s BioProcess Technology Group, is quoted in article "Gene therapies: On the rise". Appearing in Pharma Manufacturing. The piece looks at the rapid growth of cell & gene therapies and highlights companies in the field. https://t.co/r8OehIE6M1
CMC cell and gene therapy development activities have had difficulties keeping pace. However, extraordinary collaborations between regulatory agencies and therapeutic companies are working to provide regulatory guidance to accelerate approvals.
https://t.co/3U8SzE4of7